Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by TinTorontoon Jun 01, 2018 9:45pm
596 Views
Post# 28114517

Another news release

Another news release

Early Warning News Release of Aurora Cannabis Inc.


NEWS PROVIDED BY

Aurora Cannabis Inc.

20:33 ET


TSX:  ACB TSX-V: HEMP

EDMONTONJune 1, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora") (TSX:  ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announces that pursuant to an Amended and Restated Private Placement Subscription Agreement dated September 15, 2017, with Hempco Food and Fiber Inc. (TSX-V:HEMP) (the "Reporting Issuer"), Aurora Cannabis Inc. (the "Acquiror") subscribed for 10,558,676 units in the share capital of the Reporting Issuer, each Unit consisted of one common share at a purchase price of $0.3075 per common share and one share purchase warrant at an exercise price of $0.41 per warrant share, exercisable up to and including November 14, 2019 (the "Offering").  The Units were purchased for gross proceeds of $3,246,797.87.

 

Concurrent with the acquisition under the Offering, the Acquiror also entered into a Call Option Agreement with Charles Holmes and Angela Holmes (the "Founders"), that allows the Acquiror to purchase up to 10,754,942 Shares in the share capital of the Reporting Issuer (50% from Charles Holmes and 50% from Angela Holmes) (the "Additional Shares") from the Founders in equal amounts. 

(collectively "the Transaction")

Prior to the Transaction, the Acquiror held Nil common shares in the share capital of the Reporting Issuer.  

On March 26, 2018, the Acquiror exercised a total of 10,558,676 warrants forming part of the Offering at an exercise price of $0.41 per warrant share for aggregate proceeds of $4,329,057.16.

On May 15, 2018, the Acquiror exercised its right under the Call Option Agreement and purchased an aggregate of 10,754,942 Additional Shares in the share capital of the Reporting Issuer (50% from Charles Holmes and 50% from Angela Holmes) at a deemed price of $0.30 per common share for aggregate proceeds of $3,226,482.60.

The Acquiror holds a total of 31,872,294 common shares in the share capital of the Reporting issuer, representing 52.69% of the 60,495,244 issued and outstanding common shares in the share capital of the Reporting Issuer.

The Acquiror will evaluate its investment in the Reporting Issuer from time to time and may, based on such evaluation, market conditions and other circumstances, increase or decrease its shareholdings as circumstances require.

An early warning report regarding this acquisition has been filed on the System for Electronic Document Analysis and Review ("SEDAR") under the Reporting Issuer's profile and can be viewed at  www.sedar.com


Bullboard Posts